posted
I had an email about this today. the message said that ILADS was getting involved but I haven't found anything saying the same.
so to answer your question, I know of them but don't know much about them.
they do have an insurance verification link so at least they will try to go through your insurance company.
Posts: 44 | From Pa | Registered: Feb 2011
| IP: Logged |
posted
There have been a couple of posts in medical about this test in the last few months. opinion seems to be divided as to how accurate the test is.
I just posted yesterday about an upcoming lecture by an ILADS doc about this test.
Will try to come back and add those links for you.
Bea Seibert
Posts: 7306 | From Martinsville,VA,USA | Registered: Oct 2004
| IP: Logged |
Ann-OH
Frequent Contributor (5K+ posts)
Member # 2020
posted
Thanks to both of you. I will check out what was said in medical. I had a message from the lab as well. I hadn't heard of them or the test before.
Ann-OH
Frequent Contributor (5K+ posts)
Member # 2020
posted
They do their stuff AND a Western Blot. I wonder how weighted the Western Blot is in their results. Or do they just do it to confirm results?
Ann - OH
Here are the basics from the company Q&A at website above:
A revolutionary new test method for the assessment of acute and chronic Borrelia burgdorferi (Lyme) specific immune response in patients.
What makes this test different? The combination of B. burgdorferi (Lyme) specific T cell response and cytokine analysis, in conjunction with standard western blot, evaluates both cellular and humoral immune responses, as well as the inflammatory response. This comprehensive assessment provides the most complete clinical analysis available.
MY Lyme Immune I.D. Comprehensive Assessment (#5652) Includes: *Immune Tolerance Test� (ITT�) Identifies T cell response specific for B. burgdorferi (Lyme) antigens, even hidden or low levels. Includes a panel of B. burgdorferi (Lyme) specific antigens that offer early and late stage identification.
Protein mitogens used:
OspC - Early antigen appears shortly after tick bite or transfer of the spirochete VlsE-1 - Late antigen appears after spirochete infection p100 - Late stage antigen DbpA - Contributes to spirochete dissemination within the host DbpB - Facilitates binding of B. burgdorferi to host cells
*Cytokine Analysis Analysis of B. burgdorferi (Lyme) antigen specific inflammatory immune response in patients. Provides guidance for effective intervention protocols.Assessment includes cytokines, chemokines, and immune growth factors:
IL-1� IL-6 IL-10 IL-13 G-CSF MCP-1 TNF-alpha
◦Western Blot Analysis (IgG and IgM) (Industry standard methodology)
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/